Stroke
Conference Coverage
Brain stimulation can improve prognosis following a stroke and other neurological diseases
The use of noninvasive brain stimulation is already within reach for the neurorehabilitation of stroke patients. “I am optimistic that in a few...
Conference Coverage
LAA closure device shown safe in groups omitted in trials
New independent studies support safety of left atrial appendage closure devices in broad array of patient types.
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
From the Journals
Depressive symptoms tied to higher stroke risk, worse outcomes
The findings of a new study build on prior research examining the link between depression and stroke.
From the Journals
Artificial sweetener in ‘keto foods’ tied to cardiovascular risk
Artificial sweeteners are “generally recognized as safe” by the FDA, so there is no requirement for long-term safety studies, and little is known...
Literature Review
Spinal cord stimulation restores poststroke arm, hand function in two patients
“We found that after a few weeks of use, some of these improvements endure when the stimulation is switched off, indicating exciting avenues for...
Feature
Two cups of coffee increase heart dangers with hypertension
Too much coffee may raise blood pressure and lead to anxiety, heart palpitations, and difficulty sleeping.
Conference Coverage
Endovascular therapy benefits large infarction: ANGEL-ASPECT
Trial stopped early because a planned interim analysis showed efficacy of endovascular therapy.
Conference Coverage
Similar effect of early, late BP reduction in stroke: CATIS-2
“Antihypertensive treatment can be delayed for at least 7 days following ischemic stroke onset, unless there are severe acute comorbidities that...
Conference Coverage
Thrombolysis not necessary in mild nondisabling stroke: ARAMIS
‘We may be doing more harm than good with alteplase in this patient population,’ says expert.
From the Journals
Diabetes drug tied to lower dementia risk
Risk for dementia is doubled in adults with T2DM, say the authors of a new paper.